Intravascular Stents Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), By Product (Coronary Stents, Peripheral Stents), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2019-2029F
Global Intravascular Stents Market was valued at USD 11.98 Billion in 2023 and is anticipated t%lI%witness a steady growth in the forecast period with a CAGR of 7.30% through 2029. Intravascular stents are medical devices designed t%lI%support and maintain the patency (openness) of blood vessels, typically arteries or veins, within the human body. They are used in a medical procedure called angioplasty, which is a minimally invasive technique for treating various vascular conditions, especially those related t%lI%atherosclerosis and arterial narrowing. Intravascular stents are instrumental in restoring proper blood flow through vessels and preventing complications associated with vascular blockages. Intravascular stents are primarily used t%lI%treat vascular conditions, most commonly in the coronary arteries (coronary stents) and peripheral arteries (peripheral stents), but they can als%lI%be used in other vessels throughout the body. Stents are typically tubular, mesh-like structures made from biocompatible materials, such as stainless steel, cobalt-chromium alloys, nickel-titanium (Nitinol), or bioresorbable polymers. They can be bare metal or coated with drug-eluting coatings. Stents are placed inside the affected blood vessel during an angioplasty procedure. First, a catheter with a deflated balloon at its tip is threaded int%lI%the blocked or narrowed vessel. The balloon is inflated t%lI%compress the plaque or obstruction against the vessel wall, restoring blood flow. Then, the stent, which is mounted on the balloon, is expanded t%lI%act as a scaffold t%lI%keep the vessel open.
The global aging population is more prone t%lI%cardiovascular diseases. As the elderly population increases, s%lI%does the demand for intravascular stents. Ongoing research and innovation in stent design, materials, and coatings lead t%lI%the development of more effective and safer stents, which drive market growth. Greater awareness of cardiovascular health improved diagnostic techniques, and regular health screenings have led t%lI%earlier detection of cardiovascular conditions, resulting in more stent procedures. Factors such as sedentary lifestyles, poor dietary habits, and increased stress contribute t%lI%the rising incidence of cardiovascular diseases, boosting the demand for stents. An increasing emphasis on tracking patient outcomes and real-world evidence t%lI%determine the effectiveness of different stent types and materials is driving innovation.
Key Market Drivers
Technological Advancements
Drug-eluting stents are coated with medications that are slowly released t%lI%inhibit tissue regrowth and reduce restenosis (re-narrowing of the treated vessel). The development of various drug coatings, such as sirolimus and paclitaxel, has significantly improved the long-term efficacy of stents in preventing restenosis. Bioabsorbable stents are designed t%lI%gradually dissolve in the body over time, leaving behind only natural tissue. These stents eliminate some of the long-term issues associated with metallic stents, such as the risk of late stent thrombosis and potential interference with future procedures or imaging.
Hybrid stent designs combine the benefits of both balloon-expandable and self-expanding stents. These stents provide precise deployment and radial strength while als%lI%adapting t%lI%vessel anatomy. Some DES now use bioresorbable polymer coatings t%lI%release drugs. These coatings are absorbed by the body over time, reducing the risk of chronic inflammation and long-term complications. 3D printing technology is being used t%lI%create patient-specific stents tailored t%lI%an individual's unique vascular anatomy. This can lead t%lI%more effective and personalized treatment. Nanotechnology is being employed t%lI%improve the biocompatibility of stents, allowing for better integration with vascular tissue and reduced inflammation. Radiopaque stents are designed t%lI%be highly visible under fluoroscopy, aiding in precise placement. Radiolucent stents are transparent under X-ray, enabling better visualization of vessel structures. Advancements in coating technologies, such as nano-coatings and bioactive coatings, enhance the release of drugs and improve stent performance.
Reducing the thickness of stent struts minimizes the obstruction t%lI%blood flow, reduces the risk of restenosis, and improves deliverability during the procedure. These stents use biodegradable polymers that are gradually absorbed by the body. This technology minimizes long-term inflammation and complications associated with polymer coatings. Innovations in imaging and 3D modeling allow for the creation of stents that precisely match a patient's vascular anatomy, reducing complications and optimizing treatment. These devices combine angioplasty balloons with drug coatings t%lI%provide localized drug delivery t%lI%the treated area. They are used in conjunction with stents or as an alternative treatment option. The use of advanced materials and alloys, such as nitinol, in stent construction allows for improved flexibility, conformability, and durability. Stent manufacturers are exploring the integration of sensors int%lI%stents, enabling remote monitoring of stent performance and patient condition. This factor will help in the development of the Global Intravascular Stents Market.
Increasing Awareness and Diagnosis
Greater awareness of cardiovascular health and the availability of routine screenings and diagnostic tests have led t%lI%the early detection of cardiovascular conditions. This includes coronary artery disease, peripheral artery disease, and other vascular disorders that may require stent implantation. With improved awareness, individuals at risk of cardiovascular diseases are more likely t%lI%seek medical attention when they experience symptoms or risk factors. Early intervention can prevent disease progression and may involve the use of intravascular stents.
Timely diagnosis and treatment can reduce the severity of the disease, lower the risk of complications, and improve patient outcomes. Stent placement is often a minimally invasive and effective solution for managing these conditions. Increased awareness often leads t%lI%better patient education about cardiovascular diseases and available treatment options, including stent placement. Informed patients are more likely t%lI%participate in their healthcare decisions. Awareness campaigns and improved public knowledge about cardiovascular diseases lead t%lI%more referrals from primary care physicians and general practitioners t%lI%specialists wh%lI%may recommend stent procedures when appropriate. Increased awareness encourages individuals t%lI%manage modifiable risk factors, such as smoking, unhealthy diet, and sedentary lifestyles, which can contribute t%lI%the prevention of cardiovascular diseases and reduce the need for stent interventions.
National and regional health organizations often run screening programs and campaigns that target at-risk populations. These programs lead t%lI%increased diagnosis and may result in the use of stents as a treatment option. Global health initiatives, including World Heart Day and World Stroke Day, play a role in raising awareness about the burden of cardiovascular diseases, promoting prevention, and encouraging timely treatment when necessary. Local health departments, clinics, and healthcare organizations often engage in community outreach efforts t%lI%educate the public about heart health and the importance of early diagnosis and treatment. Awareness efforts als%lI%help reduce the stigma associated with cardiovascular diseases, making it more acceptable for individuals t%lI%discuss symptoms and seek treatment. A growing focus on cardiovascular health has led t%lI%increased research and innovation in the field of intravascular stents, resulting in more effective and safer stent designs and technologies. This factor will pace up the demand of the Global Intravascular Stents Market.
Increasing Aging Population
As individuals age, their risk of developing cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and aortic stenosis, significantly increases. These conditions often require the use of intravascular stents for treatment. Older adults are more likely t%lI%have chronic health conditions, such as diabetes, hypertension, and hyperlipidemia, which are risk factors for cardiovascular diseases. These conditions may necessitate the use of stents t%lI%manage and treat vascular complications. The aging process is associated with changes in blood vessels, such as atherosclerosis and arterial stiffening, which can lead t%lI%vascular obstructions. Stents are commonly used t%lI%address these age-related changes. Older patients often have complex medical histories, including prior cardiovascular interventions or comorbid conditions, making stent procedures a valuable treatment option t%lI%manage their healthcare needs.
Advances in healthcare and medical treatments have increased life expectancy, resulting in a larger aging population. As individuals live longer, they are more likely t%lI%experience age-related cardiovascular issues that may require stent interventions. Older adults are increasingly considered surgical candidates for stent procedures, as advancements in healthcare allow for improved outcomes and safety for elderly patients. The elderly population often prefers minimally invasive procedures like stent placement, as they typically involve shorter recovery times and reduced trauma compared t%lI%open surgeries. Aging patients may underg%lI%stent procedures as preventive interventions t%lI%address potential blockages or stenoses in their arteries before they lead t%lI%severe complications.
Stent placement can allow older adults t%lI%maintain an active and independent lifestyle, reducing the impact of cardiovascular conditions on daily activities. Older individuals, particularly in developed countries, have better access t%lI%healthcare, including specialized cardiology services that offer stent procedures. The aging population benefits from post-stent care, which helps manage their cardiovascular health and reduce the risk of complications or revascularization procedures. With longer life expectancies, older patients are more inclined t%lI%educate themselves about cardiovascular health and the available treatment options, including stent procedures. This factor will accelerate the demand of the Global Intravascular Stents Market.
Key Market Challenges
Post-Market Surveillance and Reporting
The need for long-term follow-up data t%lI%assess the safety and efficacy of intravascular stents is a considerable challenge. Stents are implanted for extended periods, and adverse events or complications may not become evident until years after the procedure. The intravascular stents market serves diverse patient populations with varying risk factors, comorbidities, and anatomical characteristics. This diversity complicates data collection and analysis, making it challenging t%lI%draw broad conclusions about stent performance. There is variability in how adverse events and complications are reported and recorded among different healthcare institutions and regions. This can hinder the aggregation and analysis of post-market data. Adverse events associated with stent use may be underreported, either due t%lI%lack of awareness or reluctance on the part of healthcare providers or patients. This can lead t%lI%incomplete data and an inaccurate assessment of stent safety. Variations in regulatory requirements and post-market surveillance expectations in different countries or regions can complicate the harmonization of data collection and reporting practices. Collating and integrating data from various sources, including electronic health records, clinical studies, and device registries, can be technically challenging, especially in cases where healthcare systems lack interoperability. Stringent patient privacy regulations and concerns can limit the sharing of patient data across institutions and borders, hindering comprehensive post-market surveillance efforts.
Market Saturation
The global intravascular stents market is relatively mature, with a well-established presence of multiple manufacturers and a wide range of stent products. This maturity can limit opportunities for significant growth. Market saturation often leads t%lI%intense competition among stent manufacturers, resulting in pricing pressures and reduced profit margins. In mature markets, there may be less room for groundbreaking innovations, as many of the key technological advancements have already been introduced. This can limit opportunities for differentiation. Most healthcare facilities, especially in developed regions, are already equipped t%lI%perform stent procedures, and many physicians are experienced in stent implantation. This saturation limits the expansion of the customer base. As the market becomes saturated, the overall growth rate may slow down, making it challenging for companies t%lI%achieve substantial revenue increases. Fierce competition often leads t%lI%price competition, which can impact the profitability of stent manufacturers. Lower prices may be required t%lI%gain or maintain market share.
Key Market Trends
Customization and Personalization
Advancements in medical imaging, such as computed tomography (CT), angiography and intravascular ultrasound (IVUS), allow for the creation of patient-specific stents. These stents are designed t%lI%match the unique vascular anatomy of each patient, improving the precision and effectiveness of the intervention. 3D printing technology is being used t%lI%manufacture stents that are customized t%lI%fit individual patients. These stents are designed based on the specific dimensions and geometry of a patient's vessels, potentially reducing complications, and improving stent performance. Personalization extends t%lI%the choice of coatings and drugs used in drug-eluting stents (DES). Different patients may respond differently t%lI%various coatings and drugs, and the ability t%lI%customize these elements can optimize patient outcomes. Customized stent solutions align with the principles of precision medicine, where medical decisions and treatments are tailored t%lI%the genetic, molecular, and clinical characteristics of individual patients. Personalization in the intravascular stents market involves assessing an individual patient's risk factors, comorbidities, and specific cardiovascular conditions. This information helps guide stent selection and treatment decisions.
Segmental Insights
Type Insights
Based on Type, Drug Eluting Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Drug-eluting stents are designed t%lI%release drugs that inhibit tissue regrowth in the stented area, reducing the risk of restenosis (renarrowing of the vessel). As a result, DES have been shown t%lI%have superior clinical outcomes compared t%lI%bare-metal stents (BMS), with lower rates of restenosis and target lesion revascularization. Because of their ability t%lI%prevent restenosis, DES reduce the need for repeat procedures, such as angioplasty or additional stent implantation. This not only improves patient outcomes but als%lI%reduces the economic burden on healthcare systems. DES often have special coatings or drugs that help prevent the formation of blood clots (thrombosis) inside the stent, reducing the risk of in-stent thrombosis and its associated complications. DES are particularly effective in treating complex lesions, such as long and calcified blockages, which are challenging t%lI%address with BMS. This makes DES a preferred choice for many interventional procedures. The DES segment offers a wide array of choices, including various drug types (e.g., sirolimus, paclitaxel, zotarolimus) and stent designs, allowing healthcare providers t%lI%tailor the treatment t%lI%the patient's specific needs.
Product Insights
Based on Product, Coronary Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Coronary artery disease (CAD) is one of the most common cardiovascular diseases worldwide. It involves the narrowing or blockage of the coronary arteries that supply blood t%lI%the heart muscle. Given the high incidence of CAD, there is a substantial demand for coronary stents t%lI%treat this condition. Coronary stents are frequently used in life-threatening situations, such as heart attacks (myocardial infarctions) or unstable angina. These emergency situations require prompt intervention t%lI%restore blood flow t%lI%the heart muscle, and coronary stents play a critical role in this regard. Coronary stent implantation procedures, both elective and emergency, are well-established and widely practiced in cardiology. Physicians have extensive experience and training in performing these procedures, which contributes t%lI%their popularity. Clinical trials and studies have consistently shown the effectiveness of coronary stents in improving patient outcomes, reducing symptoms, and preventing complications associated with CAD, such as heart attacks. Continuous research and development efforts in the field of coronary stents have led t%lI%innovations in design, materials, and drug-eluting technologies, resulting in safer and more effective stents. These advancements enhance the appeal of coronary stents t%lI%both healthcare professionals and patients.
Regional Insights
Based on Region, North America have emerged as the dominating region in the Global Intravascular Stents Market in 2023. North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. This infrastructure includes state-of-the-art hospitals, well-equipped cardiac care centers, and many skilled healthcare professionals, which are essential for the diagnosis and treatment of cardiovascular diseases, often requiring intravascular stents. The region has a significant prevalence of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and other conditions that require stent implantation. Factors such as a sedentary lifestyle, poor dietary habits, and the aging population contribute t%lI%this high incidence. And als%lI%the region has been at the forefront of technological advancements in the field of medical devices, including intravascular stents. Many leading stent manufacturers and research institutions are in the region, driving innovation and product development. North American healthcare systems tend t%lI%adopt new medical technologies and treatments relatively early, contributing t%lI%a larger market share for innovative stent products, such as drug-eluting stents and bioresorbable stents. The presence of well-established health insurance systems in North America helps patients access and afford stent procedures. This insurance coverage encourages the adoption of stents as a treatment option.
Key Market Players
%lI%Boston Scientific Corporation
%lI%Medtronic plc.
%lI%Terum%lI%Medical Corporation
%lI%Abbott Laboratories Inc.
%lI%BIOTRONIK SE & Co. KG
%lI%Stryker Corporation
%lI%Microport Scientific Corporation
%lI%Stentys S.A.
%lI%HELLMAN & FRIEDMAN LLC
%lI%B. Braun SE
Report Scope:
In this report, the Global Intravascular Stents Market has been segmented int%lI%the following categories, in addition t%lI%the industry trends which have als%lI%been detailed below:
%lI%Intravascular Stents Market, By Type:
%lI%Drug Eluting Stents
%lI%Bare Metal Stents
%lI%Bioabsorbable Stents
%lI% Intravascular Stents Market, By Product:
%lI%Coronary Stents
%lI%Peripheral Stents
%lI%Intravascular Stents Market, By End-Use:
%lI%Hospitals & Clinics
%lI%Ambulatory Surgical Centers
%lI%Others
%lI%Intravascular Stents Market, By Region:
%lI%North America
%lI%United States
%lI%Canada
%lI%Mexico
%lI%Asia Pacific
%lI%China
%lI%India
%lI%South Korea
%lI%Australia
%lI%Japan
%lI%Europe
%lI%Germany
%lI%France
%lI%United Kingdom
%lI%Spain
%lI%Italy
%lI%South America
%lI%Brazil
%lI%Argentina
%lI%Colombia
%lI%Middle East & Africa
%lI%South Africa
%lI%Saudi Arabia
%lI%UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Intravascular Stents Market.
Available Customizations:
Global Intravascular Stents Market report with the given market data, Tech Sci Research offers customizations according t%lI%a company's specific needs. The following customization options are available for the report:
Company Information
%lI%Detailed analysis and profiling of additional market players (up t%lI%five).
The global aging population is more prone t%lI%cardiovascular diseases. As the elderly population increases, s%lI%does the demand for intravascular stents. Ongoing research and innovation in stent design, materials, and coatings lead t%lI%the development of more effective and safer stents, which drive market growth. Greater awareness of cardiovascular health improved diagnostic techniques, and regular health screenings have led t%lI%earlier detection of cardiovascular conditions, resulting in more stent procedures. Factors such as sedentary lifestyles, poor dietary habits, and increased stress contribute t%lI%the rising incidence of cardiovascular diseases, boosting the demand for stents. An increasing emphasis on tracking patient outcomes and real-world evidence t%lI%determine the effectiveness of different stent types and materials is driving innovation.
Key Market Drivers
Technological Advancements
Drug-eluting stents are coated with medications that are slowly released t%lI%inhibit tissue regrowth and reduce restenosis (re-narrowing of the treated vessel). The development of various drug coatings, such as sirolimus and paclitaxel, has significantly improved the long-term efficacy of stents in preventing restenosis. Bioabsorbable stents are designed t%lI%gradually dissolve in the body over time, leaving behind only natural tissue. These stents eliminate some of the long-term issues associated with metallic stents, such as the risk of late stent thrombosis and potential interference with future procedures or imaging.
Hybrid stent designs combine the benefits of both balloon-expandable and self-expanding stents. These stents provide precise deployment and radial strength while als%lI%adapting t%lI%vessel anatomy. Some DES now use bioresorbable polymer coatings t%lI%release drugs. These coatings are absorbed by the body over time, reducing the risk of chronic inflammation and long-term complications. 3D printing technology is being used t%lI%create patient-specific stents tailored t%lI%an individual's unique vascular anatomy. This can lead t%lI%more effective and personalized treatment. Nanotechnology is being employed t%lI%improve the biocompatibility of stents, allowing for better integration with vascular tissue and reduced inflammation. Radiopaque stents are designed t%lI%be highly visible under fluoroscopy, aiding in precise placement. Radiolucent stents are transparent under X-ray, enabling better visualization of vessel structures. Advancements in coating technologies, such as nano-coatings and bioactive coatings, enhance the release of drugs and improve stent performance.
Reducing the thickness of stent struts minimizes the obstruction t%lI%blood flow, reduces the risk of restenosis, and improves deliverability during the procedure. These stents use biodegradable polymers that are gradually absorbed by the body. This technology minimizes long-term inflammation and complications associated with polymer coatings. Innovations in imaging and 3D modeling allow for the creation of stents that precisely match a patient's vascular anatomy, reducing complications and optimizing treatment. These devices combine angioplasty balloons with drug coatings t%lI%provide localized drug delivery t%lI%the treated area. They are used in conjunction with stents or as an alternative treatment option. The use of advanced materials and alloys, such as nitinol, in stent construction allows for improved flexibility, conformability, and durability. Stent manufacturers are exploring the integration of sensors int%lI%stents, enabling remote monitoring of stent performance and patient condition. This factor will help in the development of the Global Intravascular Stents Market.
Increasing Awareness and Diagnosis
Greater awareness of cardiovascular health and the availability of routine screenings and diagnostic tests have led t%lI%the early detection of cardiovascular conditions. This includes coronary artery disease, peripheral artery disease, and other vascular disorders that may require stent implantation. With improved awareness, individuals at risk of cardiovascular diseases are more likely t%lI%seek medical attention when they experience symptoms or risk factors. Early intervention can prevent disease progression and may involve the use of intravascular stents.
Timely diagnosis and treatment can reduce the severity of the disease, lower the risk of complications, and improve patient outcomes. Stent placement is often a minimally invasive and effective solution for managing these conditions. Increased awareness often leads t%lI%better patient education about cardiovascular diseases and available treatment options, including stent placement. Informed patients are more likely t%lI%participate in their healthcare decisions. Awareness campaigns and improved public knowledge about cardiovascular diseases lead t%lI%more referrals from primary care physicians and general practitioners t%lI%specialists wh%lI%may recommend stent procedures when appropriate. Increased awareness encourages individuals t%lI%manage modifiable risk factors, such as smoking, unhealthy diet, and sedentary lifestyles, which can contribute t%lI%the prevention of cardiovascular diseases and reduce the need for stent interventions.
National and regional health organizations often run screening programs and campaigns that target at-risk populations. These programs lead t%lI%increased diagnosis and may result in the use of stents as a treatment option. Global health initiatives, including World Heart Day and World Stroke Day, play a role in raising awareness about the burden of cardiovascular diseases, promoting prevention, and encouraging timely treatment when necessary. Local health departments, clinics, and healthcare organizations often engage in community outreach efforts t%lI%educate the public about heart health and the importance of early diagnosis and treatment. Awareness efforts als%lI%help reduce the stigma associated with cardiovascular diseases, making it more acceptable for individuals t%lI%discuss symptoms and seek treatment. A growing focus on cardiovascular health has led t%lI%increased research and innovation in the field of intravascular stents, resulting in more effective and safer stent designs and technologies. This factor will pace up the demand of the Global Intravascular Stents Market.
Increasing Aging Population
As individuals age, their risk of developing cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and aortic stenosis, significantly increases. These conditions often require the use of intravascular stents for treatment. Older adults are more likely t%lI%have chronic health conditions, such as diabetes, hypertension, and hyperlipidemia, which are risk factors for cardiovascular diseases. These conditions may necessitate the use of stents t%lI%manage and treat vascular complications. The aging process is associated with changes in blood vessels, such as atherosclerosis and arterial stiffening, which can lead t%lI%vascular obstructions. Stents are commonly used t%lI%address these age-related changes. Older patients often have complex medical histories, including prior cardiovascular interventions or comorbid conditions, making stent procedures a valuable treatment option t%lI%manage their healthcare needs.
Advances in healthcare and medical treatments have increased life expectancy, resulting in a larger aging population. As individuals live longer, they are more likely t%lI%experience age-related cardiovascular issues that may require stent interventions. Older adults are increasingly considered surgical candidates for stent procedures, as advancements in healthcare allow for improved outcomes and safety for elderly patients. The elderly population often prefers minimally invasive procedures like stent placement, as they typically involve shorter recovery times and reduced trauma compared t%lI%open surgeries. Aging patients may underg%lI%stent procedures as preventive interventions t%lI%address potential blockages or stenoses in their arteries before they lead t%lI%severe complications.
Stent placement can allow older adults t%lI%maintain an active and independent lifestyle, reducing the impact of cardiovascular conditions on daily activities. Older individuals, particularly in developed countries, have better access t%lI%healthcare, including specialized cardiology services that offer stent procedures. The aging population benefits from post-stent care, which helps manage their cardiovascular health and reduce the risk of complications or revascularization procedures. With longer life expectancies, older patients are more inclined t%lI%educate themselves about cardiovascular health and the available treatment options, including stent procedures. This factor will accelerate the demand of the Global Intravascular Stents Market.
Key Market Challenges
Post-Market Surveillance and Reporting
The need for long-term follow-up data t%lI%assess the safety and efficacy of intravascular stents is a considerable challenge. Stents are implanted for extended periods, and adverse events or complications may not become evident until years after the procedure. The intravascular stents market serves diverse patient populations with varying risk factors, comorbidities, and anatomical characteristics. This diversity complicates data collection and analysis, making it challenging t%lI%draw broad conclusions about stent performance. There is variability in how adverse events and complications are reported and recorded among different healthcare institutions and regions. This can hinder the aggregation and analysis of post-market data. Adverse events associated with stent use may be underreported, either due t%lI%lack of awareness or reluctance on the part of healthcare providers or patients. This can lead t%lI%incomplete data and an inaccurate assessment of stent safety. Variations in regulatory requirements and post-market surveillance expectations in different countries or regions can complicate the harmonization of data collection and reporting practices. Collating and integrating data from various sources, including electronic health records, clinical studies, and device registries, can be technically challenging, especially in cases where healthcare systems lack interoperability. Stringent patient privacy regulations and concerns can limit the sharing of patient data across institutions and borders, hindering comprehensive post-market surveillance efforts.
Market Saturation
The global intravascular stents market is relatively mature, with a well-established presence of multiple manufacturers and a wide range of stent products. This maturity can limit opportunities for significant growth. Market saturation often leads t%lI%intense competition among stent manufacturers, resulting in pricing pressures and reduced profit margins. In mature markets, there may be less room for groundbreaking innovations, as many of the key technological advancements have already been introduced. This can limit opportunities for differentiation. Most healthcare facilities, especially in developed regions, are already equipped t%lI%perform stent procedures, and many physicians are experienced in stent implantation. This saturation limits the expansion of the customer base. As the market becomes saturated, the overall growth rate may slow down, making it challenging for companies t%lI%achieve substantial revenue increases. Fierce competition often leads t%lI%price competition, which can impact the profitability of stent manufacturers. Lower prices may be required t%lI%gain or maintain market share.
Key Market Trends
Customization and Personalization
Advancements in medical imaging, such as computed tomography (CT), angiography and intravascular ultrasound (IVUS), allow for the creation of patient-specific stents. These stents are designed t%lI%match the unique vascular anatomy of each patient, improving the precision and effectiveness of the intervention. 3D printing technology is being used t%lI%manufacture stents that are customized t%lI%fit individual patients. These stents are designed based on the specific dimensions and geometry of a patient's vessels, potentially reducing complications, and improving stent performance. Personalization extends t%lI%the choice of coatings and drugs used in drug-eluting stents (DES). Different patients may respond differently t%lI%various coatings and drugs, and the ability t%lI%customize these elements can optimize patient outcomes. Customized stent solutions align with the principles of precision medicine, where medical decisions and treatments are tailored t%lI%the genetic, molecular, and clinical characteristics of individual patients. Personalization in the intravascular stents market involves assessing an individual patient's risk factors, comorbidities, and specific cardiovascular conditions. This information helps guide stent selection and treatment decisions.
Segmental Insights
Type Insights
Based on Type, Drug Eluting Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Drug-eluting stents are designed t%lI%release drugs that inhibit tissue regrowth in the stented area, reducing the risk of restenosis (renarrowing of the vessel). As a result, DES have been shown t%lI%have superior clinical outcomes compared t%lI%bare-metal stents (BMS), with lower rates of restenosis and target lesion revascularization. Because of their ability t%lI%prevent restenosis, DES reduce the need for repeat procedures, such as angioplasty or additional stent implantation. This not only improves patient outcomes but als%lI%reduces the economic burden on healthcare systems. DES often have special coatings or drugs that help prevent the formation of blood clots (thrombosis) inside the stent, reducing the risk of in-stent thrombosis and its associated complications. DES are particularly effective in treating complex lesions, such as long and calcified blockages, which are challenging t%lI%address with BMS. This makes DES a preferred choice for many interventional procedures. The DES segment offers a wide array of choices, including various drug types (e.g., sirolimus, paclitaxel, zotarolimus) and stent designs, allowing healthcare providers t%lI%tailor the treatment t%lI%the patient's specific needs.
Product Insights
Based on Product, Coronary Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Coronary artery disease (CAD) is one of the most common cardiovascular diseases worldwide. It involves the narrowing or blockage of the coronary arteries that supply blood t%lI%the heart muscle. Given the high incidence of CAD, there is a substantial demand for coronary stents t%lI%treat this condition. Coronary stents are frequently used in life-threatening situations, such as heart attacks (myocardial infarctions) or unstable angina. These emergency situations require prompt intervention t%lI%restore blood flow t%lI%the heart muscle, and coronary stents play a critical role in this regard. Coronary stent implantation procedures, both elective and emergency, are well-established and widely practiced in cardiology. Physicians have extensive experience and training in performing these procedures, which contributes t%lI%their popularity. Clinical trials and studies have consistently shown the effectiveness of coronary stents in improving patient outcomes, reducing symptoms, and preventing complications associated with CAD, such as heart attacks. Continuous research and development efforts in the field of coronary stents have led t%lI%innovations in design, materials, and drug-eluting technologies, resulting in safer and more effective stents. These advancements enhance the appeal of coronary stents t%lI%both healthcare professionals and patients.
Regional Insights
Based on Region, North America have emerged as the dominating region in the Global Intravascular Stents Market in 2023. North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. This infrastructure includes state-of-the-art hospitals, well-equipped cardiac care centers, and many skilled healthcare professionals, which are essential for the diagnosis and treatment of cardiovascular diseases, often requiring intravascular stents. The region has a significant prevalence of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and other conditions that require stent implantation. Factors such as a sedentary lifestyle, poor dietary habits, and the aging population contribute t%lI%this high incidence. And als%lI%the region has been at the forefront of technological advancements in the field of medical devices, including intravascular stents. Many leading stent manufacturers and research institutions are in the region, driving innovation and product development. North American healthcare systems tend t%lI%adopt new medical technologies and treatments relatively early, contributing t%lI%a larger market share for innovative stent products, such as drug-eluting stents and bioresorbable stents. The presence of well-established health insurance systems in North America helps patients access and afford stent procedures. This insurance coverage encourages the adoption of stents as a treatment option.
Key Market Players
%lI%Boston Scientific Corporation
%lI%Medtronic plc.
%lI%Terum%lI%Medical Corporation
%lI%Abbott Laboratories Inc.
%lI%BIOTRONIK SE & Co. KG
%lI%Stryker Corporation
%lI%Microport Scientific Corporation
%lI%Stentys S.A.
%lI%HELLMAN & FRIEDMAN LLC
%lI%B. Braun SE
Report Scope:
In this report, the Global Intravascular Stents Market has been segmented int%lI%the following categories, in addition t%lI%the industry trends which have als%lI%been detailed below:
%lI%Intravascular Stents Market, By Type:
%lI%Drug Eluting Stents
%lI%Bare Metal Stents
%lI%Bioabsorbable Stents
%lI% Intravascular Stents Market, By Product:
%lI%Coronary Stents
%lI%Peripheral Stents
%lI%Intravascular Stents Market, By End-Use:
%lI%Hospitals & Clinics
%lI%Ambulatory Surgical Centers
%lI%Others
%lI%Intravascular Stents Market, By Region:
%lI%North America
%lI%United States
%lI%Canada
%lI%Mexico
%lI%Asia Pacific
%lI%China
%lI%India
%lI%South Korea
%lI%Australia
%lI%Japan
%lI%Europe
%lI%Germany
%lI%France
%lI%United Kingdom
%lI%Spain
%lI%Italy
%lI%South America
%lI%Brazil
%lI%Argentina
%lI%Colombia
%lI%Middle East & Africa
%lI%South Africa
%lI%Saudi Arabia
%lI%UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Intravascular Stents Market.
Available Customizations:
Global Intravascular Stents Market report with the given market data, Tech Sci Research offers customizations according t%lI%a company's specific needs. The following customization options are available for the report:
Company Information
%lI%Detailed analysis and profiling of additional market players (up t%lI%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL INTRAVASCULAR STENTS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents)
5.2.2. By Product (Coronary Stents, Peripheral Stents)
5.2.3. By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
5.2.4. By Region
5.2.5. By Company (2023)
5.3. Market Map
6. ASIA PACIFIC INTRAVASCULAR STENTS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Product
6.2.3. By End-Use
6.2.4. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Intravascular Stents Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Product
6.3.1.2.3. By End-Use
6.3.2. India Intravascular Stents Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Product
6.3.2.2.3. By End-Use
6.3.3. Australia Intravascular Stents Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Product
6.3.3.2.3. By End-Use
6.3.4. Japan Intravascular Stents Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Product
6.3.4.2.3. By End-Use
6.3.5. South Korea Intravascular Stents Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Product
6.3.5.2.3. By End-Use
7. EUROPE INTRAVASCULAR STENTS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Product
7.2.3. By End-Use
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Intravascular Stents Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By End-Use
7.3.2. Germany Intravascular Stents Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By End-Use
7.3.3. Spain Intravascular Stents Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By End-Use
7.3.4. Italy Intravascular Stents Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Product
7.3.4.2.3. By End-Use
7.3.5. United Kingdom Intravascular Stents Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Product
7.3.5.2.3. By End-Use
8. NORTH AMERICA INTRAVASCULAR STENTS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Product
8.2.3. By End-Use
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Intravascular Stents Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By End-Use
8.3.2. Mexico Intravascular Stents Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By End-Use
8.3.3. Canada Intravascular Stents Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By End-Use
9. SOUTH AMERICA INTRAVASCULAR STENTS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Product
9.2.3. By End-Use
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Intravascular Stents Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By End-Use
9.3.2. Argentina Intravascular Stents Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By End-Use
9.3.3. Colombia Intravascular Stents Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By End-Use
10. MIDDLE EAST AND AFRICA INTRAVASCULAR STENTS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Product
10.2.3. By End-Use
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Intravascular Stents Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By End-Use
10.3.2. Saudi Arabia Intravascular Stents Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By End-Use
10.3.3. UAE Intravascular Stents Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product
10.3.3.2.3. By End-Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL INTRAVASCULAR STENTS MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. PESTLE ANALYSIS
16. COMPETITIVE LANDSCAPE
16.1. Boston Scientific Corporation
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (In case of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2. Medtronic plc.
16.3. Terumo Medical Corporation
16.4. Abbott Laboratories Inc.
16.5. BIOTRONIK SE & Co. KG
16.6. Stryker Corporation
16.7. Microport Scientific Corporation
16.8. Stentys S.A.
16.9. HELLMAN & FRIEDMAN LLC
16.10.B. Braun SE
17. STRATEGIC RECOMMENDATIONS
18. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL INTRAVASCULAR STENTS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents)
5.2.2. By Product (Coronary Stents, Peripheral Stents)
5.2.3. By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
5.2.4. By Region
5.2.5. By Company (2023)
5.3. Market Map
6. ASIA PACIFIC INTRAVASCULAR STENTS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Product
6.2.3. By End-Use
6.2.4. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Intravascular Stents Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Product
6.3.1.2.3. By End-Use
6.3.2. India Intravascular Stents Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Product
6.3.2.2.3. By End-Use
6.3.3. Australia Intravascular Stents Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Product
6.3.3.2.3. By End-Use
6.3.4. Japan Intravascular Stents Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Product
6.3.4.2.3. By End-Use
6.3.5. South Korea Intravascular Stents Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Product
6.3.5.2.3. By End-Use
7. EUROPE INTRAVASCULAR STENTS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Product
7.2.3. By End-Use
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Intravascular Stents Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By End-Use
7.3.2. Germany Intravascular Stents Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By End-Use
7.3.3. Spain Intravascular Stents Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By End-Use
7.3.4. Italy Intravascular Stents Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Product
7.3.4.2.3. By End-Use
7.3.5. United Kingdom Intravascular Stents Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Product
7.3.5.2.3. By End-Use
8. NORTH AMERICA INTRAVASCULAR STENTS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Product
8.2.3. By End-Use
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Intravascular Stents Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By End-Use
8.3.2. Mexico Intravascular Stents Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By End-Use
8.3.3. Canada Intravascular Stents Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By End-Use
9. SOUTH AMERICA INTRAVASCULAR STENTS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Product
9.2.3. By End-Use
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Intravascular Stents Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By End-Use
9.3.2. Argentina Intravascular Stents Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By End-Use
9.3.3. Colombia Intravascular Stents Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By End-Use
10. MIDDLE EAST AND AFRICA INTRAVASCULAR STENTS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Product
10.2.3. By End-Use
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Intravascular Stents Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By End-Use
10.3.2. Saudi Arabia Intravascular Stents Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By End-Use
10.3.3. UAE Intravascular Stents Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product
10.3.3.2.3. By End-Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL INTRAVASCULAR STENTS MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. PESTLE ANALYSIS
16. COMPETITIVE LANDSCAPE
16.1. Boston Scientific Corporation
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (In case of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2. Medtronic plc.
16.3. Terumo Medical Corporation
16.4. Abbott Laboratories Inc.
16.5. BIOTRONIK SE & Co. KG
16.6. Stryker Corporation
16.7. Microport Scientific Corporation
16.8. Stentys S.A.
16.9. HELLMAN & FRIEDMAN LLC
16.10.B. Braun SE
17. STRATEGIC RECOMMENDATIONS
18. ABOUT US & DISCLAIMER
